A Phase I Dose Escalation Study Evaluating Vintafolide (MK-8109) Chemotherapy Alone or in Combination in Adult Subjects With Advanced Cancers
Phase of Trial: Phase I
Latest Information Update: 13 Feb 2015
At a glance
- Drugs Vintafolide (Primary) ; Carboplatin; Paclitaxel
- Indications Fallopian tube cancer; Non-small cell lung cancer; Ovarian cancer; Peritoneal cancer; Solid tumours
- Focus Adverse reactions; Therapeutic Use
- Sponsors Endocyte; Merck Sharp & Dohme
- 30 Oct 2014 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov .
- 17 Jul 2014 Planned End Date changed from 1 Nov 2015 to 1 Sep 2014 as reported by ClinicalTrials.gov record.
- 17 Jul 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.